Chinook Therapeutics Overview

Chinook Therapeutics Selling, General & Admin

Selling, General & Admin expenses for KDNY.

Quarterly SG&A Expenses

$12.99M

↑ 50.46% YoY

As of Jun 30, 2023

Annual SG&A Expenses (TTM)

$44.18M

↑ 42.11% YoY

Trailing 12 months ending Jun 30, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin